Josh blacher

Biography

   Mr. Blacher also held positions in portfolio manage­ment at Deutsche Asset Management and equity research at Morgan Stanley, as well as in mergers & acqui­si­tions at Lehman Brothers. Mr. Blacher holds an MBA in Finance from Columbia Business School.

Research Interest

  Mr. Blacher joined Therapix in 2017 bringing with him more than nine years of experi­ence in biotech-related finan­cial manage­ment, including as a CFO of a NASDAQ-traded company, business devel­op­ment, investing and opera­tions, as well as 14 years in capital markets. Prior to joining Therapix, Mr. Blacher was the CFO for Galmed Pharmaceuticals, and earlier served as Director of Business Development at Teva Innovative Ventures, Teva Pharmaceuticals’ early- and mid-stage invest­ment and in-licensing arm.